Search results for "Time factor"

showing 10 items of 3219 documents

Performance of a Highly Sensitive Mycobacterium tuberculosis Complex Real-Time PCR Assay for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence …

2018

ABSTRACT The potential impact of routine real-time PCR testing of respiratory specimens from patients with presumptive tuberculosis in terms of diagnostic accuracy and time to tuberculosis treatment inception in low-prevalence settings remains largely unexplored. We conducted a prospective intervention cohort study. Respiratory specimens from 1,020 patients were examined by acid-fast bacillus smear microscopy, tested by a real-time Mycobacterium tuberculosis complex PCR assay (Abbott RealTi me MTB PCR), and cultured in mycobacterial media. Seventeen patients tested positive by PCR (5 were acid-fast bacillus smear positive and 12 acid-fast bacillus smear negative), and Mycobacterium tubercul…

AdultMale0301 basic medicineMicrobiology (medical)medicine.medical_specialtyTime FactorsTuberculosisAdolescent030106 microbiologyAntitubercular AgentsReal-Time Polymerase Chain ReactionMycobacterium tuberculosisYoung Adult03 medical and health sciencesTuberculosis diagnosisInternal medicineHumansMedicineProspective StudiesTuberculosis PulmonaryAgedAged 80 and overBacteriological TechniquesMicroscopybiologybusiness.industryMycobacteriology and Aerobic ActinomycetesMycobacterium tuberculosisMiddle Agedmedicine.diseasebiology.organism_classificationIntervention studiesReal-time polymerase chain reactionMolecular Diagnostic TechniquesMycobacterium tuberculosis complexFemaleNontuberculous mycobacteriabusinessCohort studyJournal of Clinical Microbiology
researchProduct

Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries

2016

AbstractWe aimed at investigating the distribution and risk of second primary cancers (SPCs) in multiple myeloma (MM) survivors in Germany and Sweden to provide etiological understanding of SPCs and insight into their incidence rates and recording practices. MM patients diagnosed in 1997–2010 at age ≥15 years were selected from the Swedish (nationwide) and 12 German cancer registries. Standardized incidence ratios (SIRs) were used to assess risk of a specific SPC compared to risk of the same first cancer in the corresponding background population. Among 18,735 survivors of first MM in Germany and 7,560 in Sweden, overall 752 and 349 SPCs were recorded, respectively. Significantly elevated S…

AdultMale0301 basic medicineOncologyPediatricsmedicine.medical_specialtyTime FactorsMyeloidAdolescentNervous System NeoplasmsPopulationAntineoplastic AgentsArticle03 medical and health sciences0302 clinical medicineRisk FactorsGermanyInternal medicinemedicineHumansRegistriesSurvivorseducationMultiple myelomaAgedSwedeneducation.field_of_studyMultidisciplinarybusiness.industryIncidence (epidemiology)CancerNeoplasms Second PrimaryMiddle Agedmedicine.diseaseKidney NeoplasmsLeukemia Myeloid AcuteLeukemiaEarly Diagnosis030104 developmental biologymedicine.anatomical_structure030220 oncology & carcinogenesisEpidemiology ; Cancer epidemiology ; MyelomaEtiologyFemaleMultiple MyelomabusinessKidney cancerScientific Reports
researchProduct

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.

2020

Background: Current availability of several biologic treatments for severe asthma makes it possible to choose the most appropriate for each patient. Sometimes a good percentage of patients with severe asthma may be eligible for biologics that target either the allergic phenotype or the eosinophilic one, but not all respond to that selected as first choice. The aim of our real-life study was to assess whether, for patients with severe eosinophilic allergic asthma, not previously controlled by the anti-IgE omalizumab, the shift to another biologic targeting interleukin-5, such as mepolizumab, may represent a good therapeutic choice. Methods: A total of 41 consecutive patients with severe, per…

AdultMale0301 basic medicinePulmonary and Respiratory Medicinesevere asthmamedicine.medical_specialtyTime FactorsSevere asthmamepolizumab omalizumab severe asthma switchingOmalizumabSettore MED/10 - Malattie Dell'Apparato RespiratorioAntibodies Monoclonal HumanizedSeverity of Illness Index03 medical and health sciences0302 clinical medicinereal lifeAnti-Allergic AgentsHumansMedicineswitching.Pharmacology (medical)Anti-Asthmatic AgentsPulmonary EosinophiliaIntensive care medicineLungOriginal ResearchAgedRetrospective Studieslcsh:RC705-779switchingDrug Substitutionbusiness.industrymepolizumablcsh:Diseases of the respiratory systemMiddle AgedAsthmaTreatment Outcome030104 developmental biologyItaly030228 respiratory systemomalizumabFemalebusinessMepolizumabmedicine.drug
researchProduct

Evolution of oral neoplasm in an andalusian population (Spain)

2018

Background Head and neck cancer are one of the most common neoplasm pathologies in humans. The aim of this study was to analyze the type, characteristics, treatment and evolution of oral neoplasm or precancerous lesion in a sample of Andalusian population (Spain) derived from the Oncology Rehabilitation Hospital Unit during a period of 20 years. Material and Methods A retrospective descriptive study was carried out during the years 1991 and 2011 analyzing the type, characteristics, treatment and follow-up of oral neoplasm in the Oral and Maxillofacial Surgery Unit of the Universitary Hospital “Virgen del Rocío”. The inclusion criteria were patients whose underlying pathology was any type of…

AdultMale0301 basic medicineRehabilitation hospitalmedicine.medical_specialtyTime FactorsPopulationYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansYoung adulteducationGeneral DentistryRetrospective Studieseducation.field_of_studybusiness.industryResearchHead and neck cancerRetrospective cohort studyOral NeoplasmMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.disease030104 developmental biologyOtorhinolaryngologyEpidermoid carcinomaSpain030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASOral and maxillofacial surgeryFemaleMouth NeoplasmsSurgeryOral Surgerybusiness
researchProduct

Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study

2016

Objective The biological heterogeneity of hepatocellular carcinoma (HCC) makes prognosis difficult. We translate the results of a genome-wide high-throughput analysis into a tool that accurately predicts at presentation tumour growth and survival of patients with HCC.Design Ultrasound surveillance identified HCC in 78 (training set) and 54 (validation set) consecutive patients with cirrhosis. Patients underwent two CT scans 6 weeks apart (no treatment in-between) to determine tumour volumes (V-0 and V-1) and calculate HCC doubling time. Baseline-paired HCC and surrounding tissue biopsies for microarray study (Agilent Whole Human Genome Oligo Microarrays) were also obtained. Predictors of su…

AdultMale0301 basic medicinemedicine.medical_specialtyTime FactorsCarcinoma HepatocellularTime FactorMicroarrayHepatocellular carcinomamolecular carcinogenesisGastroenterologyliver imagingHEPATOCELLULAR CARCINOMA; LIVER IMAGING; MOLECULAR CARCINOGENESIS; MOLECULAR ONCOLOGY; Adult; Aged; Aged 80 and over; Carcinoma Hepatocellular; Disease Progression; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neovascularization Pathologic; Prospective Studies; Survival Rate; Time Factors; Tumor Burden; Medicine (all); Gastroenterology03 medical and health sciencesmolecular oncology0302 clinical medicineHepatocellular carcinoma liver imaging molecular carcinogenesis molecular oncologyInternal medicinemedicineCarcinomaHumansDoubling timeProspective StudiesProspective cohort studySurvival rateAgedAged 80 and overNeovascularization Pathologicbusiness.industryProportional hazards modelLiver NeoplasmsGastroenterologyMiddle Agedmedicine.diseaseTumor BurdenSurvival RateProspective Studie030104 developmental biologyQuartileLiver Neoplasm030220 oncology & carcinogenesisHepatocellular carcinomaDisease ProgressionFemalebusinessHumanGut
researchProduct

Sign effect in adolescents: Within‐subject comparison of delay discounting of hypothetical monetary gains and losses

2020

The purpose of this article is to contribute to the research on the sign effect, steeper discounting of gains compared to losses, by offering results from an experiment using a "double-delay" procedure on adolescents. Twenty-four 14-year-old schoolchildren completed a computer-based test consisting of choices of Smaller-Sooner (SS) and Larger-Later (LL) hypothetical monetary gains and losses. Within-subject comparison and analysis of the aggregated data were conducted. Current results were also examined in light of prior research with adult participants, and variations in behavioral patterns were identified. Although the sign effect appears to be more profound in adolescents compared to adu…

AdultMale050103 clinical psychologyDiscountingTime FactorsAdolescentDelay discountingPsychology Adolescent05 social sciencesWithin personAge FactorsBehavioral patternExperimental and Cognitive PsychologyChoice BehaviorOutcome (probability)Behavioral NeuroscienceDelay DiscountingRewardImmediacyEconometricsHumans0501 psychology and cognitive sciences050102 behavioral science & comparative psychologyPsychologySign (mathematics)Journal of the Experimental Analysis of Behavior
researchProduct

The predictive value of early response in patients with depressive disorders

2016

Several randomized controlled trials have identified early response to psychotherapy as a predictor for later treatment outcome among patients with depressive disorders. However, supporting evidence under routine conditions is rare. This study evaluated the predictive value of early improvement for final outcomes in psychotherapy among depressive patients in the naturalistic setting of a German university outpatient clinic.We used the method of percent symptom reduction to classify 639 patients with major depression or dysthymic disorder who underwent an average of 40.0 sessions (SD = 16.3) of naturalistic cognitive-behavioral therapy (CBT) as having either an early response or an early non…

AdultMale050103 clinical psychologyTime FactorsPsychotherapistTreatment outcomelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawOutcome Assessment Health CareHumansOutpatient clinic0501 psychology and cognitive sciencesIn patientDepressive symptomsDepression (differential diagnoses)Depressive Disorder MajorDysthymic DisorderCognitive Behavioral Therapy05 social sciencesMiddle AgedPredictive value030227 psychiatryClinical PsychologyFemaleDysthymic DisorderPsychologyPsychotherapy Research
researchProduct

''Sex-related Trends In Participation and Performance In the 'swiss Bike Masters' From 1994-2012''

2013

Gloor, Roman Urs | Knechtle, Beat | Knechtle, Patrizia | Ruest, Christoph Alexander | Haupt, Samuel | Rosemann, Thomas | Lepers, Romuald; International audience; ''General participation in contests such as ultra-marathons and ultra-triathlons has increased considerably over the past 30 years, especially among women. This study investigated performance trends in the Swiss Bike Masters, one of the first and most prestigious mountain bike, ultra-endurance races in its class, with comparisons of participation and performance trends to similar races. The development of performance in the Swiss Bike Masters held between 1994 and 2012 was investigated by analysing the number of finishers, their ag…

AdultMale11035 Institute of General PracticeCompetitive BehaviorTime FactorsSTATES''Adolescent''GENDER-DIFFERENCESExperimental and Cognitive Psychology610 Medicine & healthAthletic Performance03 medical and health sciencesYoung Adult2809 Sensory Systems0302 clinical medicineAltitudeSex FactorsSex factorsHumans030212 general & internal medicineAgedGENDER-DIFFERENCESbiologyAthletes3205 Experimental and Cognitive Psychology[SCCO.NEUR]Cognitive science/NeuroscienceAge FactorsWOMENSex relatedMOTIVATION030229 sport sciencesMiddle Agedbiology.organism_classificationSensory SystemsBicyclingGeographySTATES[ SCCO.NEUR ] Cognitive science/NeuroscienceFemaleINJURIESCyclingDemography
researchProduct

Runners in their forties dominate ultra-marathons from 50 to 3,100 miles

2014

International audience; OBJECTIVES: This study investigated performance trends and the age of peak running speed in ultra-marathons from 50 to 3,100 miles. METHODS: The running speed and age of the fastest competitors in 50-, 100-, 200-, 1,000- and 3,100-mile events held worldwide from 1971 to 2012 were analyzed using single- and multi-level regression analyses. RESULTS: The number of events and competitors increased exponentially in 50- and 100-mile events. For the annual fastest runners, women improved in 50-mile events, but not men. In 100-mile events, both women and men improved their performance. In 1,000-mile events, men became slower. For the annual top ten runners, women improved in…

AdultMale11035 Institute of General PracticeGerontologyANTHROPOMETRYAge of Peak PerformanceTime FactorsPARTICIPATION610 Medicine & health2700 General MedicineAthletic PerformanceMuscle massUltra marathonRunningYoung AdultSex FactorsSex factorsHumansMedicineULTRAMARATHON RUNNERSMUSCLE MASSYoung adultUltra-Marathonlcsh:R5-920business.industryAEROBIC POWERRACE TIMEAge FactorsENDURANCEMOTIVATIONGeneral MedicineClinical ScienceMiddle AgedAnthropometryRunning SpeedPhysical EnduranceRegression AnalysisFemale[ SCCO ] Cognitive scienceRUNNING PERFORMANCEbusinesslcsh:Medicine (General)ULTRARUNNERSClinics
researchProduct

The age-related performance decline in ultraendurance mountain biking

2013

Haupt, Samuel | Knechtle, Beat | Knechtle, Patrizia | Ruest, Christoph Alexander | Rosemann, Thomas | Lepers, Romuald; International audience; ''The age-related changes in ultraendurance performance have been previously examined for running and triathlon but not mountain biking. The aims of this study were (i) to describe the performance trends and (ii) to analyze the age-related performance decline in ultraendurance mountain biking in a 120-km ultraendurance mountain bike race the Swiss Bike Masters from 1995 to 2009 in 9,325 male athletes. The mean (+/- SD) race time decreased from 590 +/- 80 min to 529 +/- 88 min for overall finishers and from 415 +/- 8 min to 359 +/- 16 min for the top …

AdultMale11035 Institute of General PracticeTime FactorsInjury controlAccident preventionPhysical TherapyMountain bikingPoison controlPhysical Therapy Sports Therapy and Rehabilitation610 Medicine & healthSports Therapy and RehabilitationAthletic PerformanceYoung Adult03 medical and health sciencesOFF-ROAD0302 clinical medicine2732 Orthopedics and Sports MedicineAge groupsAge relatedMARATHONHumansMedicineOrthopedics and Sports Medicine''OFF-ROAD3612 Physical Therapy Sports Therapy and RehabilitationAnalysis of VarianceGENDER-DIFFERENCESTRIATHLONTRENDS''business.industry[SCCO.NEUR]Cognitive science/NeuroscienceAge Factors030229 sport sciencesMiddle AgedTRENDSBicycling[ SCCO.NEUR ] Cognitive science/NeurosciencePhysical EnduranceFemalebusiness030217 neurology & neurosurgeryDemographyOff road cycling
researchProduct